Pfizer said Wednesday that it entered into a definitive agreement to acquire all of the shares of Therachon for $340 million upfront, with a further $470 million in milestone payments linked to ...
An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the results of a phase 2 trial....